CLINICAL_TRIALS
trial_result
· 2020-03-11
Clinical Trial Update: A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope
Summary
Post-marketing study on the Cormatrix Cangaroo ECM Envelope for cardiovascular disease has completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Elutia Inc. | Conditions: Cardiovascular Disease | Status: COMPLETED | Results posted: 2020-03-11